SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : FDA - Stocks close to approval: List them here
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: STEVEN OLIVEIRA who wrote (2)7/2/1996 9:34:00 AM
From: eugenic1   of 83
 
Matritech (nmps) is awaiting approval for US sales of its NMP-22
bladder cancer marker test kits. Non-invasive, cheap, and twice as
accurate as current cytology procedure. FDA said it is "approvable"
back in DEC.95 based on some additional info which is currently in
their hands. Stock price has retreated of late as folks loose patience.
See thread under biotechs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News